India's Pharmaceutical Exports

Country Profile

Barbados

Barbados is a developing market for Indian pharmaceuticals — $3.91M in FY 2025–26, with 4.1× growth over the past decade. Medicines accounts for 88% of shipments, with vaccines contributing $69K. The compound annual growth rate since FY2015 stands at 13.7%.

🇧🇧 $3.91M · 4.1× growth since FY2015 · 13.7% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$3.91M
Exports FY2025–26 DGCIS
4.1×
Growth FY2015→2026
13.7%
CAGR FY2015→2026
88%
Medicines Share
5
Product Categories Supplied
Barbados is a developing market for Indian pharmaceuticals — $3.91M in FY 2025–26, with 4.1× growth over the past decade. Medicines accounts for 88% of shipments, with vaccines contributing $69K. The compound annual growth rate since FY2015 stands at 13.7%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $3.45M (88.2%) Surgical & Hospital Supplies $149K (3.8%) Traditional & Herbal $126K (3.2%) Medicine Ingredients $117K (3.0%) Vaccines $69K (1.8%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Barbados in the RBI overseas direct investment dataset (2011–2026).